within Pharmacolibrary.Drugs.ATC.D;

model D10AF02
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.35,
    Cl             = 0.00023333333333333333,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.04,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.011666666666666665,
    Tlag           = 15.0,            
    Vdp             = 0.02,
    k12             = 22,
    k21             = 22
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D10AF02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Erythromycin is a macrolide antibiotic used to treat various bacterial infections, especially in individuals allergic to penicillins. It is effective against respiratory tract, skin, and soft tissue infections and is still approved and used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Mergenhagen, KA, et al., &amp; Russo, TA (2020). Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions. <i>Antimicrobial agents and chemotherapy</i> 64(3) –. DOI:<a href=&quot;https://doi.org/10.1128/AAC.02167-19&quot;>10.1128/AAC.02167-19</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31871085/&quot;>https://pubmed.ncbi.nlm.nih.gov/31871085</a></p></li><li><p>Welling, PG, &amp; Craig, WA (1978). Pharmacokinetics of intravenous erythromycin. <i>Journal of pharmaceutical sciences</i> 67(8) 1057–1059. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600670809&quot;>10.1002/jps.2600670809</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/671237/&quot;>https://pubmed.ncbi.nlm.nih.gov/671237</a></p></li><li><p>Escudero, AI, et al., &amp; Escudero, E (2018). Pharmacokinetics of deflazacort in rabbits after intravenous and oral administration and its interaction with erythromycin. <i>Journal of veterinary pharmacology and therapeutics</i> 41(1) e10–e15. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12442&quot;>10.1111/jvp.12442</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28741668/&quot;>https://pubmed.ncbi.nlm.nih.gov/28741668</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D10AF02;
